These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

961 related articles for article (PubMed ID: 18237867)

  • 1. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
    Haj-Sheykholeslami A; Rakhshani N; Amirzargar A; Rafiee R; Shahidi SM; Nikbin B; Khosravi F; Massarrat S
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
    Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study.
    Sipponen P; Ranta P; Helske T; Kääriäinen I; Mäki T; Linnala A; Suovaniemi O; Alanko A; Härkönen M
    Scand J Gastroenterol; 2002 Jul; 37(7):785-91. PubMed ID: 12190091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
    Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
    Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of serum pepsinogen level and gastric mucosal changes of residents in the high incidence area of gastric cancer].
    Zhang XH; Huang B; Wang JL; Li YH; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):507-11. PubMed ID: 17147114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q; Ran ZH; Xiao SD
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care.
    Germaná B; Di Mario F; Cavallaro LG; Moussa AM; Lecis P; Liatoupolou S; Comparato G; Carloni C; Bertiato G; Battiestel M; Papa N; Aragona G; Cavestro GM; Iori V; Merli R; Bertolini S; Caruana P; Franzé A
    Dig Liver Dis; 2005 Jul; 37(7):501-8. PubMed ID: 15975537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
    Kiyohira K; Yoshihara M; Ito M; Haruma K; Tanaka S; Chayama K
    J Gastroenterol; 2003; 38(4):332-8. PubMed ID: 12743772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship among serum pepsinogens, serum gastrin, gastric mucosal histology and H. pylori virulence factors in a paediatric population.
    Lopes AI; Palha A; Lopes T; Monteiro L; Oleastro M; Fernandes A
    Scand J Gastroenterol; 2006 May; 41(5):524-31. PubMed ID: 16638693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
    Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
    Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of serum pepsinogens I and II, gastrin-17 and anti-helicobacter pylori antibodies in histological diagnoses of atrophic gastritis.
    Irvani S; Hashemi MR; Moghadam KG; Saeidee S; Khavaran K; Najari O; Ranavardi M; Nasiri S; Salmasian H; Rohanizadegan M
    Minerva Gastroenterol Dietol; 2010 Mar; 56(1):13-7. PubMed ID: 20190719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pepsinogen and gastrin in the noninvasive diagnosis of gastric atrophy. A case-control study in Peruvian population].
    Colarossi A; Inga R; Prochazka R; Reyes U; Bussalleu A; Barúa RL
    Rev Gastroenterol Peru; 2011; 31(2):110-5. PubMed ID: 21836650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up study on a high risk population of gastric cancer in north China by serum pepsinogen assay.
    Sun LP; Gong YH; Wang L; Gong W; Yuan Y
    J Dig Dis; 2008 Feb; 9(1):20-6. PubMed ID: 18251790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study.
    Väänänen H; Vauhkonen M; Helske T; Kääriäinen I; Rasmussen M; Tunturi-Hihnala H; Koskenpato J; Sotka M; Turunen M; Sandström R; Ristikankare M; Jussila A; Sipponen P
    Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):885-91. PubMed ID: 12867799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The non-invasive diagnosis of precancerous changes of stomach mucosa.
    Pasechnikov VD; Chukov SZ; Kotelevets SM; Mostovov AN; Polyakova MB; Mernova VP
    Rocz Akad Med Bialymst; 2004; 49():66-71. PubMed ID: 15631316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potentialities of a serological method in diagnosis of atrophic gastritis].
    Pimenov SI; Makarenko EV
    Ter Arkh; 2008; 80(2):15-21. PubMed ID: 18372589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum gastrin and the pepsinogen I/II ratio as markers for diagnosis of premalignant gastric lesions.
    Shafaghi A; Mansour-Ghanaei F; Joukar F; Sharafkhah M; Mesbah A; Askari K; Geranmayeh S; Mehrvarz A; Souti F; Sokhanvar H; Fakhrieh S; Aminian K; Yousefi-Mashhour M; Khosh-Sorur M; Rasoulian J
    Asian Pac J Cancer Prev; 2013; 14(6):3931-6. PubMed ID: 23886209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.
    Al-Assi MT; Miki K; Walsh JH; Graham DP; Asaka M; Graham DY
    Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.